Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

Published 2009 View Full Article

Authors

Keywords

Journal

ARTHRITIS AND RHEUMATISM

Volume 62, Issue 1, Pages 222-233

Publisher

Wiley

Online

2009-12-29

DOI

10.1002/art.27233

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

ARTHRITIS AND RHEUMATISM

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Ask a Question. Answer a Question.